Clinical Trials / Chinese Sinovac Testing COVID-19 Vaccine in Brazil
In the race to develop the world’s first COVID-19 vaccine, Brazil – now one of the world’s…
brazil
Brazil / EMS Sales Soar; Irregularities in Indian Vaccine Deal; Personalised Medicine Challenges
The latest news from Brazilian pharma, including an investigation into the country’s deal with Indian lab Bharat Biotech to purchase COVID-19 vaccines; the IP and regulatory challenges around personalised medicine…
Brazil / Six Trends in the OTC Market Post-COVID-19
Panorama Faramceutico’s editorial team look at how the ongoing COVID-19 pandemic stands to affect Brazil’s over…
Brazil / Top 5 Pharma Companies
Six of the top ten companies in the Brazilian pharma market are domestic.* Read on for an introduction to some of…
In Conversation
Maria del Pilar Muñoz – Vice President Sustainability…
Maria del Pilar Muñoz, vice-president in charge of M&A and Sustainability at Eurofarma, one of the largest and most innovative pharmaceutical companies in Brazil with operations in 20 countries across…
Interview: Paulo Vitor de Andrade – Founder and…
Paulo Vitor de Andrade, founder and director of Grupo Polar, elaborates on his journey to build the Brazilian company of reference in cold chain solutions and the company’s relentless efforts…
Interview: Poul Sorensen – Director, Geistlich Pharma…
Poul Sorensen, director of Geistlich Pharma in Brazil, details the importance of educational activities for Geistlich’s business, the affiliate’s desire to bring new segments of Geistlich’s portfolio to Brazil and…
Latest Reports
Brazil Pharma Report 2018
- 2018
With an exit from a period of recession in 2017, a new era of change and positivity is underway in Brazil. Stakeholders from across the public and private sectors are pulling together through strategic partnerships and dialogues to increase both the quantity and quality of the healthcare provided to the 160 million Brazilians who rely on public healthcare as well as the 47 million who are privately insured. Topics covered in this comprehensive report include the opportunities identified by MNCs in Brazil; regulatory upgrades and shifts in government priorities; the strategies and successes of some of Brazil’s standout…
Latest Reports
Brazil Pharma Report
- 2012
News Roundup / Latin America Pharma June 2020
In recent pharma news from around Latin America, countries are beginning to manufacture their own tests and…
LatAm / Big Indian Investment; Argentina's COVID-19 Woes; Cannabis ‘Green Rush’ in Mexico
The latest from healthcare and the life sciences in Latin America, including the most recent wave of Indian pharma…
News Roundup / Brazilian Pharma April 2020
Below we highlight recent news in Brazilian pharma, including the impact of coronavirus as well as legal and…
Brazil / EMS Sales Soar; Irregularities in Indian Vaccine Deal; Personalised Medicine Challenges
The latest news from Brazilian pharma, including an investigation into the country’s deal with Indian lab Bharat…
Talent / Pharma Leadership Strategies for Brazil
Three seasoned pharma executives with a wealth of experience working in Brazil offer their insights on leadership…
LatAm / COVID-19 and the Brazilian Pharma Supply Chain
The editorial team at Panorama Farmaceutico explain how the COVID-19 pandemic and global trade flow stoppages are…